Lincoln Pharmaceuticals Limited

NSE LINCOLN.NS

Lincoln Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2024: USD 0.56

Lincoln Pharmaceuticals Limited EPS (Diluted) is USD 0.56 for the year ending March 31, 2024, a 26.09% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Lincoln Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2023 was USD 0.44, a -2.89% change year over year.
Lincoln Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2022 was USD 0.46, a 7.45% change year over year.
Lincoln Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2021 was USD 0.42, a 24.36% change year over year.
Lincoln Pharmaceuticals Limited EPS (Diluted) for the year ending March 31, 2020 was USD 0.34, a -2.63% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

NSE: LINCOLN.NS

Lincoln Pharmaceuticals Limited

CEO	Mr. Mahendrabhai Gulabdas Patel B.A, LLB
IPO Date	Dec. 17, 2015
Location	India
Headquarters	Lincoln House
Employees	1,687
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Key trends

Past 5 years